Investing

Neurocrine Biosciences : NBIX

NBIX

Stock Data

$131.78

$0.11 (0.08%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Neurocrine Biosciences Inc is a biopharmaceutical company based in San Diego, California, focusing on developing treatments for neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio includes INGREZZA for tardive dyskinesia, ALKINDI for adrenal insufficiency, and several products for conditions like Huntington’s disease, endometriosis, and uterine fibroids. The company is also advancing a range of candidates for conditions such as developmental and epileptic encephalopathy, major depressive disorder, and schizophrenia, among others. Neurocrine Biosciences maintains collaborations with various pharmaceutical companies to enhance its research and development efforts.

All Neurocrine Biosciences Articles

91 Articles

Lee Jackson | Feb 24, 2026 at 8:00 AM EST

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Blackstone, Blue Owl Capital, Booking Holdings, Cheniere Energy, Comcast, Domino’s Pizza, KeyCorp, Qualcomm, and More

Pre-Market Stock Futures: Futures are trading higher this morning after a dreadful day to start the trading week. Various reasons…

Lee Jackson | Jan 8, 2026 at 8:09 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Coinbase Global, Digital Realty Trust, Intuit, Reddit, Roku, Tyler Technologies, and More

Pre-Market Stock Futures: The futures are trading lower on Thursday after investors and traders tapped the brakes on the 2026…

Joel South | Oct 28, 2025 at 8:03 PM EDT

Neurocrine Biosciences Beats Estimates But Wall Street Punishes The Stock

Neurocrine Biosciences (NASDAQ: NBIX | NBIX Price Prediction) delivered a decisive earnings beat in Q3, posting adjusted EPS of $2.17…

Will Ashworth | Mar 17, 2025 at 3:01 PM EDT

Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks 

If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t…

Trey Thoelcke | Feb 5, 2025 at 8:45 AM EST

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big…

Lee Jackson | Aug 31, 2023 at 8:45 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Best Buy, Carnival, Caterpillar, Foot Locker, Peloton, Texas Instruments and More

Thursday's top analyst upgrades and downgrades included Best Buy, Carnival, Caterpillar, Centene, ChargePoint, Foot Locker, Hewlett Packard Enterprise, Palo Alto…

Lee Jackson | Aug 3, 2023 at 8:55 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: AMD, Caesars, Caterpillar, CrowdStrike, Electronic Arts, Estee Lauder, KeyCorp, Match, Sirius XM, SoFi and More

Thursday's top analyst upgrades and downgrades included Advanced Micro Devices, Caesars Entertainment, Caterpillar, CrowdStrike, Crown Castle, Electronic Arts, Estee Lauder,…

Lee Jackson | Jul 25, 2023 at 8:49 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: American Express, Apple, Conagra, Estee Lauder, Livent, Microsoft, Netflix, Nvidia, Shopify, Tesla and More

Tuesday's top analyst upgrades and downgrades included American Express, Apple, AppLovin, Conagra Brands, D.R. Horton, Estee Lauder, Juniper Networks, Livent,…

Lee Jackson | Jul 7, 2023 at 8:55 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: American Express, Keurig Dr Pepper, Meta, Teva Pharmaceutical and More

Friday's top analyst upgrades and downgrades included American Express, Aptiv, BorgWarner, First Horizon, Keurig Dr Pepper, Meta Platforms, MGIC Investment,…

Lee Jackson | May 5, 2023 at 8:53 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: CVS Health, McDonald’s, Newell Brands, PacWest, ZoomInfo and More

Friday's top analyst upgrades and downgrades included Builders FirstSource, CVS Health, DHT, Incyte, McDonald's, Newell Brands, PacWest Bancorp, Wingstop and…

Lee Jackson | May 3, 2023 at 8:54 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Coinbase, CrowdStrike, Dell, HP, Kohl’s, Palo Alto Networks, Penn Entertainment, SoFi, Zscaler and More

Wednesday's top analyst upgrades and downgrades included Annaly Capital Management, Capri, Chegg, Coinbase Global, CrowdStrike, Dell Technologies, Fortinet, HP, Kohl's,…

Lee Jackson | Mar 31, 2023 at 8:52 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: American Tower, Charles Schwab, DraftKings, Enphase Energy, Juniper Networks, Philip Morris, Sunrun and More

Friday's top analyst upgrades and downgrades included American Tower, Charles Schwab, Crown Castle, DiamondRock Hospitality, DraftKings, Enphase Energy, GitLab, Interpublic…

Lee Jackson | Feb 6, 2023 at 8:50 AM EST

Monday’s Top Analyst Upgrades and Downgrades: Boeing, Cardinal Health, ConocoPhillips, Ford, Meta Platforms, Nordstrom, Spirit Aerosystems and More

Monday's top analyst upgrades and downgrades included Bill.com, Boeing, Cardinal Health, Cognizant Technology Solutions, ConocoPhillips, C3.ai, Enphase Energy, Ford, International…

Lee Jackson | Nov 15, 2022 at 8:51 AM EST

Tuesday’s Top Analyst Upgrades and Downgrades: AMD, Medical Properties Trust, Meta Platforms, Nvidia, Redfin and More

Tuesday's top analyst upgrades and downgrades included Advanced Micro Devices, Arista Networks, Biogen, CyberArk Software, Global Payments, Kanzhun, Medical Properties…

Lee Jackson | Sep 27, 2022 at 8:50 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Costco, Exxon, FedEx, Lucid, Medtronic, Micron Technology, Salesforce, Six Flags, Unity Software and More

Tuesday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Costco Wholesale, Dollar General, Exxon Mobil, FedEx, Horizon Therapeutics, Hyatt Hotels,…